Vault-13

NUVECTIS PHARMA INC NVCT

COM · Common Stock · CUSIP 67080T108

13 institutional holders
1,417,3041.4m shares reported held*
9.7% of all shares outstanding*
$10.0mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 14.6m as of 2022-11-07, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $7.09.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Soleus Private Equity Fund III, L.P. 13G · passive investor new · filed 2026-08-06 5.1% new 1.6m≈ $30.3m 2026-08-06

Insider purchases and sales in Q3 2022

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
505Q4 20: 0 buyingQ4 20: 0 sellingQ1 21: 0 buyingQ1 21: 0 sellingQ1 21Q2 21: 0 buyingQ2 21: 0 sellingQ3 21: 0 buyingQ3 21: 0 sellingQ3 21Q4 21: 0 buyingQ4 21: 0 sellingQ1 22: 3 buyingQ1 22: 0 sellingQ1 22Q2 22: 5 buyingQ2 22: 0 sellingQ3 22: 2 buyingQ3 22: 0 sellingQ3 22
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20200—0——
Q1 20210—0——
Q2 20210—0——
Q3 20210—0——
Q4 20210—0——
Q1 20223$1.4m0——
Q2 20225$565.3k0——
Q3 20222$410.1k0——
DateInsiderTradeSharesPrice ValueTheir holding
2022-09-30 BENTSUR RON Chairman & CEO, director Bought 500 $7.46 $3.7k500 shares +<1%
2022-09-28 BENTSUR RON Chairman & CEO, director Bought 500 $7.23 $3.6k500 shares +<1%
2022-09-26 BENTSUR RON Chairman & CEO, director Bought 500 $7.69 $3.8k500 shares +<1%
2022-09-23 BENTSUR RON Chairman & CEO, director Bought 1,000 $7.93 $7.9k1.0k shares +<1%
2022-09-23 Shemesh Shay Chief Dev. & Ops. Officer Bought 220 $7.87 $1.7k220 shares +<1%
2022-09-02 BENTSUR RON Chairman & CEO, director Bought 1,200 $8.37 $10.0k1.2k shares +<1%
2022-09-02 Shemesh Shay Chief Dev. & Ops. Officer Bought 404 $8.31 $3.4k404 shares +<1%
2022-09-01 Shemesh Shay Chief Dev. & Ops. Officer Bought 1,530 $8.07 $12.3k1.5k shares +<1%
2022-09-01 BENTSUR RON Chairman & CEO, director Bought 500 $8.11 $4.1k500 shares +<1%
2022-08-31 Shemesh Shay Chief Dev. & Ops. Officer Bought 1,476 $8.07 $11.9k1.5k shares +<1%
2022-08-29 BENTSUR RON Chairman & CEO, director Bought 1,000 $9.07 $9.1k1.0k shares +<1%
2022-08-23 BENTSUR RON Chairman & CEO, director Bought 500 $9.00 $4.5k500 shares +<1%
2022-08-19 BENTSUR RON Chairman & CEO, director Bought 5,000 $8.99 $45.0k5.0k shares +<1%
2022-08-18 BENTSUR RON Chairman & CEO, director Bought 14,426 $8.58 $123.8k14.4k shares +0%
2022-08-11 BENTSUR RON Chairman & CEO, director Bought 19,669 $8.40 $165.2k19.7k shares +1%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q3 2022

#ManagerLocationShares Value% of their portfolioChangeShares change
1 SABBY MANAGEMENT, LLC 9.46% of their portfolio MIAMI BEACH, FL 632,979633.0k $4.5m $4.5m 9.46% —
2 Ronit Capital LLP 5.43% of their portfolio LONDON, X0 562,547562.5k $4.0m $4.0m 5.43% —
3 BALDWIN WEALTH PARTNERS LLC/MA 0.13% of their portfolio Marion, MA 133,000133.0k $943.0k $943.0k 0.13% —
4 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 31,44131.4k $222.0k $222.0k 0.00% —
5 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 27,06127.1k $192.0k $192.0k 0.00% —
6 BlackRock Inc. 0.00% of their portfolio New York, NY 14,00314.0k $100.0k $100.0k 0.00% —
7 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 11,70011.7k $83.0k $83.0k 0.00% —
8 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 4,0524.1k $29.0k $29.0k 0.00% —
9 UBS Group AG 0.00% of their portfolio ZURICH, V8 220220 $2.0k $2.0k 0.00% —
10 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 201201 $1.0k $1.0k 0.00% —
11 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 7676 $1.0k $1.0k 0.00% —
12 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 2424 $0 $0 0.00% —
13 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% —